Eisai Co., Ltd.

4523.T
Drug Manufacturers - Specialty & Generic
2026/02/17 Updated
Market Cap: $9.2B (¥1.4T)
Stock Price: $32.69 (¥4,998)
Exchange Rate: 1 USD = ¥152.91

Notice Regarding New Executive Officer Structure

Eisai Co., Ltd. has decided on a new executive officer structure effective April 1, 2026. Haruo Naito will continue as Representative Executive Officer CEO, with multiple executive officer position changes and resignations announced.

Importance:
Page Updated: February 9, 2026
IR Disclosure Date: February 9, 2026

Key Figures

  • Representative Executive Officer CEO: Haruo Naito (Continued)
  • Representative Executive Officer Senior Managing Officer COO and Chief Growth Officer: Keisuke Naito (Continued)
  • Departing Executive Officer: Gary Hendler (Managing Executive Officer)

AI要約

Overview of the New Executive Officer Structure

Eisai Co., Ltd. has decided on a new executive officer structure effective April 1, 2026. Haruo Naito continues as Representative Executive Officer CEO, and Keisuke Naito continues as Representative Executive Officer Senior Managing Officer COO and Chief Growth Officer. Additionally, multiple executive officers’ positions, including Chief Business Officer and Head of Internal Audit, are specified. The changes include new roles and revisions to areas of responsibility to strengthen the organizational structure.

Departing Executive Officer and Future Impact

It was announced that Gary Hendler, who served as Managing Executive Officer, will resign. This personnel change aims to refresh the management structure, clarifying the roles and responsibilities of each executive officer, which is expected to improve management efficiency and strengthen business execution capabilities. For investors, this provides confirmation of stability in management and continuity in growth strategies.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.